172 related articles for article (PubMed ID: 2120243)
21. Role of c-myc and other genes in interleukin 2 regulated CT6 T lymphocytes and their malignant variants.
Cleveland JL; Rapp UR; Farrar WL
J Immunol; 1987 May; 138(10):3495-504. PubMed ID: 3106484
[TBL] [Abstract][Full Text] [Related]
22. Cellular oncogenes and lymphocyte activation.
Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
24. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
25. Effects of interferon-gamma on proto-oncogene expression during induction of human monocytic differentiation.
Sariban E; Mitchell T; Griffin J; Kufe DW
J Immunol; 1987 Mar; 138(6):1954-8. PubMed ID: 3102606
[TBL] [Abstract][Full Text] [Related]
26. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
27. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
Farrell RE; Greene JJ
J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
[TBL] [Abstract][Full Text] [Related]
28. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
[TBL] [Abstract][Full Text] [Related]
29. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
[TBL] [Abstract][Full Text] [Related]
30. c-myc and c-fos gene regulation during mouse liver regeneration.
Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
[TBL] [Abstract][Full Text] [Related]
31. Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase.
Rabbani SA; Gladu J; Mazar AP; Henkin J; Goltzman D
J Cell Physiol; 1997 Aug; 172(2):137-45. PubMed ID: 9258335
[TBL] [Abstract][Full Text] [Related]
32. Differentiation of F9 cells is independent of c-myc expression.
Nishikura K; Kim U; Murray JM
Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
[TBL] [Abstract][Full Text] [Related]
33. Cyclic AMP-mediated suppression of normal and neoplastic B cell proliferation is associated with regulation of myc and Ha-ras protooncogenes.
Blomhoff HK; Smeland EB; Beiske K; Blomhoff R; Ruud E; Bjøro T; Pfeifer-Ohlsson S; Watt R; Funderud S; Godal T
J Cell Physiol; 1987 Jun; 131(3):426-33. PubMed ID: 3036888
[TBL] [Abstract][Full Text] [Related]
34. Transcription of protooncogenes during stimulation of normal human B lymphocytes.
Smeland EB; Blomhoff HK; Ohlsson R; De Lange Davies C; Funderud S; Boye E
Eur J Immunol; 1988 Nov; 18(11):1847-50. PubMed ID: 3060364
[TBL] [Abstract][Full Text] [Related]
35. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
Klemsz MJ; Justement LB; Palmer E; Cambier JC
J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
[TBL] [Abstract][Full Text] [Related]
36. Proto-oncogene expression in cloned T lymphocytes: mitogens and growth factors induce different patterns of expression.
Reed JC; Alpers JD; Scherle PA; Hoover RG; Nowell PC; Prystowsky MB
Oncogene; 1987 May; 1(2):223-8. PubMed ID: 3501855
[TBL] [Abstract][Full Text] [Related]
37. Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.
Sharp NA; Luscombe MJ; Clemens MJ
Oncogene; 1989 Aug; 4(8):1043-6. PubMed ID: 2548145
[TBL] [Abstract][Full Text] [Related]
38. Regulation of cell cycle duration by c-myc levels.
Karn J; Watson JV; Lowe AD; Green SM; Vedeckis W
Oncogene; 1989 Jun; 4(6):773-87. PubMed ID: 2660073
[TBL] [Abstract][Full Text] [Related]
39. Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line.
Miller WH; Moy D; Li A; Grippo JF; Dmitrovsky E
Oncogene; 1990 Apr; 5(4):511-7. PubMed ID: 2158037
[TBL] [Abstract][Full Text] [Related]
40. Continuous maintenance of transformed fibroblasts under reduced serum conditions: utility as a model system for investigating growth factor-specific effects in nonquiescent cells.
Mulder KM; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):450-8. PubMed ID: 2647770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
